Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis-Reference-Cited by-同舟云学术

Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis

Published:2012-11-21 Issue:2 Volume:71 Page:431-439
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Qi Wei-Xiang,Lin Feng,Sun Yuan-jue,Tang Li-Na,He Ai-Na,Yao Yang,Shen Zan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-012-2025-5.pdf

Reference45 articles.

1. Sitohy B, Nagy JA, Dvorak HF (2012) Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res 72(8):1909–1914

2. Tie J, Desai J (2012) Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system. Crit Rev Oncog 17(1):51–67

3. Ferrara N, Hillan KJ, Gerber HP, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3(5):391–400

4. US Food and Drug Administration. Highlights of Prescribing Information. Votrient (pazopanib) tablets. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022465lbl.pdf . Accessed 11 Jun 2012

5. European Medicines Agency. CHMPassessment report Votrient. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001141/WC500094275.pdf . Accessed 11 Jun 2012

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity Management of Systemic Kidney Cancer Therapies;Hematology/Oncology Clinics of North America;2023-10

2. Cardiovascular Toxicities Associated with Tyrosine Kinase Inhibitors;Current Cardiology Reports;2023-02-16

3. Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma;Biomedicines;2023-01-11

4. A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors;Pancreas;2022-08

5. Hydrogen Sulfide Biology and Its Role in Cancer;Molecules;2022-05-25